Business
Canada suspends use of AstraZeneca COVID vaccine for people under the age of 55 after new data emerges – 7NEWS.com.au
The pause comes for safety reasons after the risk of blood clots was revealed to be 10 times higher than previously thought.
Canada has suspended the use of the Oxford-AstraZeneca coronavirus vaccine for people under age 55 following concerns it might be linked to rare blood clots.
The National Advisory Committee on Immunisation had recommended the pause for safety reasons and the Canadian provinces, which administer health in the country, announced the suspension Monday.
There is substantial uncertainty about the benefit of providing AstraZeneca COVID-19 vaccines to adults under 55 given the potential risks, said Dr…
-
Business16 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business12 hours agoDicker Data rides the AI trend to double digit growth
-
Business20 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Noosa News20 hours agoOld Translink app canned, and new version ‘worse than paper map from 2015’